CDK6 Cancer Research Results
CDK6, Cyclin-dependent kinase 6: Click to Expand ⟱
| Source: |
| Type: |
Cyclin-dependent kinase 6 (CDK6) is another important regulator of the cell cycle, particularly involved in the transition from the G1 phase to the S phase.
CDK6 is frequently overexpressed in various cancers, and its expression levels can serve as a prognostic marker. Targeting CDK6 with specific inhibitors, such as palbociclib (which also targets CDK4), has shown promise in clinical settings, particularly in hormone receptor-positive breast cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Ovarian, |
MDAH-2774 |
|
|
|
TumCP↓,
TumCI↓,
TumCMig↓,
Apoptosis↑,
ROS↑,
miR-21↓,
miR-130a↓,
Casp8∅, Caspase-8, Caspase-10, Cyclin D1, Cyclin D2, CDK6, CDK4, FADD, TRADD, FAS, DR4 and DR5 gene mRNA expression changes were found insignificant in boric acid treated group compared with control
Casp10∅,
cycD1/CCND1∅,
CDK6∅,
CDK4∅,
FADD∅,
DR4∅,
DR5∅,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Cell Death ⓘ
Apoptosis↑, 1, Casp10∅, 1, Casp8∅, 1, DR4∅, 1, DR5∅, 1, FADD∅, 1,
Transcription & Epigenetics ⓘ
miR-21↓, 1,
Cell Cycle & Senescence ⓘ
CDK4∅, 1, cycD1/CCND1∅, 1,
Migration ⓘ
miR-130a↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6∅, 1,
Total Targets: 15
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CDK6, Cyclin-dependent kinase 6
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:895 State#:% Dir#:6
wNotes=on sortOrder:rid,rpid
Home Page